Aligos Therapeutics, Inc. (ALGS) Total liabilities 2020–2025
Aligos Therapeutics, Inc. (ALGS) total liabilities at each fiscal year-end, per SEC filings.
$35.0MFY2025 · since FY2020: $45.3M → $35.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $35.0M | -64.7% |
| FY2024 | $99.1M | +66.6% |
| FY2023 | $59.4M | +38.9% |
| FY2022 | $42.8M | -15.5% |
| FY2021 | $50.6M | +11.9% |
| FY2020 | $45.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice